SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052539
Filing Date
2020-11-09
Accepted
2020-11-09 16:31:01
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20200930.htm   iXBRL 10-Q 2177338
2 EX-10.1 arna-ex101_105.htm EX-10.1 140771
3 EX-31.1 arna-ex311_6.htm EX-31.1 15029
4 EX-31.2 arna-ex312_11.htm EX-31.2 15421
5 EX-32.1 arna-ex321_12.htm EX-32.1 8839
  Complete submission text file 0001564590-20-052539.txt   6075886

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20200930.xsd EX-101.SCH 31073
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20200930_cal.xml EX-101.CAL 39120
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20200930_def.xml EX-101.DEF 88746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200930_lab.xml EX-101.LAB 252595
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200930_pre.xml EX-101.PRE 181647
11 EXTRACTED XBRL INSTANCE DOCUMENT arna-10q_20200930_htm.xml XML 1034433
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 201298154
SIC: 2834 Pharmaceutical Preparations